Member Spotlight: Herantis Pharma – aiming to stop the progression of Parkinson’s disease

Nov 10

Made by Cells is back for 2026! Save the Date: April 29th

Nov 7

HAMK invests in biotechnology

Oct 29

Member News: Finnish Drug Discovery Center – First 1,5 Years Completed

Oct 7

BiopSense: From Research to Business - A Pandemic Funded Breakthrough

Sep 29

ETLA’s in-depth review: Biotechnology employs 19,400 in Finland – modern biotech is growing, but regulation and commercialization slow it down

Sep 9

Member Spotlight: Aqsens – The Truth Revealed by Urine

Aug 20

Member Profile: Faron Pharmaceuticals – A Finnish Innovation at the Forefront of Immunotherapy

Jun 27

Korvaa consortium unveils world-first concept shoe formed from three revolutionary biomaterial technologies

Jun 24

Member Introduction: Bonalive – Bioactive Technology as a Sustainable Treatment Against Antibiotic Resistance

Mar 24

Biotech as a critical economic asset for Europe: WifOR Institute study updated for EuropaBio

Mar 20

Member Introduction: StemSight - A New Treatment for Corneal Blindness 

Mar 10

Made by Cells - Biotech Forum - April 10th 2025

Feb 24

Eleva and 3PBIOVIAN sign strategic GMP manufacturing and technology alliance to boost capacity for Eleva’s platform and pipeline

Feb 4

Rappta Therapeutics enters into a global license agreement with SpringWorks Therapeutics for a pre-clinical first-in-class molecular glue targeting PP2A 

Jan 13

Sartar Therapeutics: A New Precision Therapy for Rare Soft Tissue Cancers

Dec 14, 2024

Finnish Bioindustries warmly welcomes Synbio Powerlabs as its newest member!

Oct 14, 2024

A new global gene therapy manufacturing facility boosts healthcare innovation in Finland

Oct 3, 2024

AP-HP has selected Aiforia as a partner for AI-assisted pathology image analysis

Sep 9, 2024

Herantis Pharma announces approval of clinical trial application for a Phase 1b trial with HER-096 in Parkinson’s disease

Sep 4, 2024